Table 1 Participant Characteristics
Overall Cohort N = 2010 | Acute Only N = 1616 | Post-Covid Condition N = 394 | |
|---|---|---|---|
Post-Covid Condition Status - n (%), | |||
Acute Only | 1616 (80%) | - | - |
Post-Covid Condition | 394 (20%) | - | - |
Age - median (IQRa) | 64 (57, 70) | 65 (58,70) | 61 (53,69) |
Sex - n (%), | |||
Female | 1280 (59%) | 928 (57%) | 282 (72%) |
Male | 888 (41%) | 688 (43%) | 112 (28%) |
Comorbidities - n (%), | |||
No | 1208 (60%) | 1012 (63%) | 196 (50%) |
Yes | 802 (40%) | 604 (37%) | 198 (50%) |
Vaccination Status at Time of Infectionb - n (%), | |||
Unvaccinatedc | 159 (7.9%) | 60 (3.7%) | 99 (25%) |
1 Dosec | 31 (1.5%) | 24 (1.5%) | 7 (2%) |
2 Doses | 192 (9.6%) | 145 (9.0%) | 47 (12%) |
3 Doses | 1460 (73%) | 1253 (78%) | 207 (53%) |
>3 Dosesc | 168 (8.5%) | 134 (8%) | 34 (9%) |
Dominant Variant at Time of Infectiond | |||
Wild Type | 67 (3.3%) | 34 (2.1%) | 33 (8.4%) |
Alpha | 109 (5.4%) | 47 (2.9%) | 62 (16%) |
Delta | 197 (9.8%) | 142 (8.8%) | 55 (14%) |
Omicron BA.1 | 295 (15%) | 234 (14%) | 61 (15%) |
Omicron BA.2 | 1341 (67%) | 1158 (72%) | 183 (46%) |
Overall Number of Submitted Samples - median (IQRa) | 5 (3,6) | 5 (4,6) | 4 (2,6) |
Number of Submitted Samples Post-Infection - median (IQRa) | 2 (1,5) | 2 (1,4) | 2 (1,6) |
